The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis

Long noncoding RNAs (lncRNAs) have been implicated in the progression of malignant tumors, including in clear cell renal cell carcinoma (ccRCC). However, the function and the specific mechanism of lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in ccRCC remains unknown. Thu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yadi Zhou, Zhenghao Zhang, Mingyi Wo, Wenfang Xu
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/561b7c365bcf4dafb39b32f4c0db47a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:561b7c365bcf4dafb39b32f4c0db47a4
record_format dspace
spelling oai:doaj.org-article:561b7c365bcf4dafb39b32f4c0db47a42021-11-26T11:19:49ZThe long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis2165-59792165-598710.1080/21655979.2021.1992330https://doaj.org/article/561b7c365bcf4dafb39b32f4c0db47a42021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.1992330https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Long noncoding RNAs (lncRNAs) have been implicated in the progression of malignant tumors, including in clear cell renal cell carcinoma (ccRCC). However, the function and the specific mechanism of lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in ccRCC remains unknown. Thus, this study explored the role of NNT-AS1 in ccRCC. We evaluated NNT-AS1 expression in ccRCC specimens. Next, CCK-8 and Transwell assays were used to evaluate cell proliferation and metastatic abilities. The interaction between miR-137 and NNT-AS1 or Y-box binding protein 1 (YBX-1) was confirmed using a dual luciferase reporter assay. The results showed that NNT-AS1 was significantly upregulated in ccRCC specimens compared with normal tissues. Inhibition of NNT-AS1 restrained ccRCC proliferation and metastasis. Mechanistically, NNT-AS1 acted as a competitive endogenous RNA to sponge miR-137, which depressed ccRCC cells proliferation and metastasis. Moreover, with the use of bioinformatics analysis, the famous oncogene YBX-1 was selected as the potential target of miR-137. Luciferase assay also confirmed the interaction between miR-137 and YBX-1. Further functional studies demonstrated that the inhibition effect of NNT-AS1 knockdown on ccRCC carcinogenesis could be partially reversed by overexpression of YBX-1, suggesting that NNT-AS1 promotes ccRCC progression through the miR-137/YBX-1 pathway. In summary, these findings indicate that NNT-AS1 promotes ccRCC progression via the miR-137/YBX-1 pathway, which may provide a promising therapeutic target for renal cell carcinoma.Yadi ZhouZhenghao ZhangMingyi WoWenfang XuTaylor & Francis Grouparticlennt-as1clear cell renal cell carcinomamir-137ybx-1BiotechnologyTP248.13-248.65ENBioengineered, Vol 12, Iss 1, Pp 8994-9005 (2021)
institution DOAJ
collection DOAJ
language EN
topic nnt-as1
clear cell renal cell carcinoma
mir-137
ybx-1
Biotechnology
TP248.13-248.65
spellingShingle nnt-as1
clear cell renal cell carcinoma
mir-137
ybx-1
Biotechnology
TP248.13-248.65
Yadi Zhou
Zhenghao Zhang
Mingyi Wo
Wenfang Xu
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
description Long noncoding RNAs (lncRNAs) have been implicated in the progression of malignant tumors, including in clear cell renal cell carcinoma (ccRCC). However, the function and the specific mechanism of lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in ccRCC remains unknown. Thus, this study explored the role of NNT-AS1 in ccRCC. We evaluated NNT-AS1 expression in ccRCC specimens. Next, CCK-8 and Transwell assays were used to evaluate cell proliferation and metastatic abilities. The interaction between miR-137 and NNT-AS1 or Y-box binding protein 1 (YBX-1) was confirmed using a dual luciferase reporter assay. The results showed that NNT-AS1 was significantly upregulated in ccRCC specimens compared with normal tissues. Inhibition of NNT-AS1 restrained ccRCC proliferation and metastasis. Mechanistically, NNT-AS1 acted as a competitive endogenous RNA to sponge miR-137, which depressed ccRCC cells proliferation and metastasis. Moreover, with the use of bioinformatics analysis, the famous oncogene YBX-1 was selected as the potential target of miR-137. Luciferase assay also confirmed the interaction between miR-137 and YBX-1. Further functional studies demonstrated that the inhibition effect of NNT-AS1 knockdown on ccRCC carcinogenesis could be partially reversed by overexpression of YBX-1, suggesting that NNT-AS1 promotes ccRCC progression through the miR-137/YBX-1 pathway. In summary, these findings indicate that NNT-AS1 promotes ccRCC progression via the miR-137/YBX-1 pathway, which may provide a promising therapeutic target for renal cell carcinoma.
format article
author Yadi Zhou
Zhenghao Zhang
Mingyi Wo
Wenfang Xu
author_facet Yadi Zhou
Zhenghao Zhang
Mingyi Wo
Wenfang Xu
author_sort Yadi Zhou
title The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
title_short The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
title_full The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
title_fullStr The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
title_full_unstemmed The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
title_sort long non-coding rna nnt-as1 promotes clear cell renal cell carcinoma progression via regulation of the mir-137/ y-box binding protein 1 axis
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/561b7c365bcf4dafb39b32f4c0db47a4
work_keys_str_mv AT yadizhou thelongnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT zhenghaozhang thelongnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT mingyiwo thelongnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT wenfangxu thelongnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT yadizhou longnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT zhenghaozhang longnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT mingyiwo longnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
AT wenfangxu longnoncodingrnanntas1promotesclearcellrenalcellcarcinomaprogressionviaregulationofthemir137yboxbindingprotein1axis
_version_ 1718409470209425408